Valeur202020212022202320242025TTMFrais de vente, généraux et administratifs59.69 M86.16 M121.47 M136.37 M139.59 M136.37 M134.72 MRecherche et développement64.69 M90.9 M126.37 M181.77 M201.78 M173.14 M171.12 MRésultat d'exploitation-60.92 M-111.44 M-146.82 M-177.45 M-209.3 M-166.9 M-164.8 MTotal des produits hors exploitation34.62 M10.63 M-2.31 M220.37 M23.59 M64.57 M62.64 MCharges d'intérêts, nettes des intérêts capitalisés000000—Résultat hors exploitation, hors charges d'intérêts34.62 M10.63 M-6.26 M200.67 M5.68 M48.17 M47.78 MRevenus/dépenses exceptionnels——3.95 M19.69 M17.9 M16.4 M14.86 MRésultat avant impôts-26.29 M-100.81 M-149.13 M42.92 M-185.71 M-102.33 M-102.16 MPart des actionnaires dans le résultat4.11 M-1.78 M11.82 M147.21 M00—Impôts345 K411 K63 K2.2 M1.41 M939 K1.32 MIntérêts ne donnant pas le contrôle / intérêts minoritaires-2.17 M-826 K-3 0000———Autres produits/charges après impôts———————Résultat net avant activités abandonnées-24.46 M-100.39 M-149.19 M40.72 M-187.12 M-103.27 M-103.48 MActivités abandonnées———————Résultat net-24.46 M-100.39 M-149.19 M40.72 M-187.12 M-103.27 M-103.48 MAjustement de dilution———————Dividendes privilégiés———————Résultat net dilué revenant aux actionnaires ordinaires-24.46 M-100.39 M-149.19 M40.72 M-187.12 M-103.27 M-103.48 MBénéfice par action de base (BPA de base)——-2.10.57-2.57-1.41-1.4Bénéfice par action dilué (BPA dilué)——-2.10.54-2.57-1.41-1.4Nombre moyen d'actions de base en circulation——71.17 M71.78 M72.67 M73.44 M—Nombre d'actions en circulation après dilution——71.17 M74.99 M72.67 M73.44 M—EBITDA-57.26 M-108.6 M-142.47 M-171.9 M-203.14 M-160.87 M-158.89 MEBIT-60.92 M-111.44 M-146.82 M-177.45 M-209.3 M-166.9 M-164.8 MCoût des ventes44.62 M72.31 M79.93 M75.97 M75.46 M113.25 M113.87 MAutres coûts des ventes———————Amortissements (flux de trésorerie)3.66 M2.85 M4.34 M5.55 M6.16 M6.02 M5.91 M
Schrodinger, Inc. - Common Stock
Schrödinger, Inc. is an international scientific software and biotechnology company that specializes in developing computational tools and software for drug discovery and materials science.
Schrödinger's software is used by pharmaceutical companies, biotech, tech, chemicals, energy, aerospace firms, and academic researchers to simulate and model the behavior of molecules at the atomic level. This accelerates the design and develops new drugs and materials more efficiently, reducing the time and cost of bringing them to market.
Schrödinger's software tools include molecular dynamics simulations, free energy calculations, quantum mechanics calculations, and virtual screening tools. The company also offers consulting services and collaborates with partners in the industry to advance the field of computational chemistry and drug discovery.